Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium (Q82092596)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

13

G Ehninger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

15

M Bornhäuser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

10

J Schetelig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

7

U Platzbecker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

M von Bonin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

F Stölzel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

A Goedecke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

K Richter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

N Wuschek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

K Hölig

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

T Illmer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Schaich

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

A Kiani

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

R Ordemann

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Schmitz

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

29 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

245-251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820709%20AND%20SRC:MED&resulttype=core&format=json

Management of acute graft-versus-host disease

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

GVHD the nuts and bolts

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Immunomodulation by mesenchymal stem cells and clinical experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatc

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021

No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.316

7 January 2021